TEPMETKO
Identification of Tepmetko
| No description |
Google image searchProduct monograph
Active ingredient
tepotinib (tepotinib hydrochloride), 225 MG
DIN: 02516322
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: EMD SERONO, A DIVISION OF EMD INC., CANADA
Date: 07-OCT-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
- L01EX21 — TEPOTINIB (ATC/DDD)
Reference brand drug: Tepmetko
